Sagimet Biosciences Inc.
SGMT
$5.14
-$0.07-1.34%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -3.06% | -6.95% | -13.25% | -4.42% | -0.81% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 22.39% | 129.62% | 61.95% | -42.04% | -75.31% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -3.80% | -36.95% | -10.70% | 91.79% | 13.76% |
| Total Current Assets | -2.57% | -6.07% | -12.92% | -4.39% | -2.81% |
|
|
|||||
| Total Current Assets | -2.57% | -6.07% | -12.92% | -4.39% | -2.81% |
| Net Property, Plant & Equipment | -32.17% | -24.34% | 300.00% | -50.65% | -32.46% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -9.28% | -6.55% | -6.00% | -8.79% | -8.31% |
|
|
|||||
| Total Accounts Payable | -69.15% | 120.87% | -40.40% | 126.18% | 23.70% |
| Total Accrued Expenses | -22.87% | -7.60% | 34.19% | 30.86% | 4.73% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -32.17% | -24.34% | 289.74% | -50.00% | -32.76% |
| Total Finance Division Other Current Liabilities | 237.50% | 700.00% | -98.41% | 1,160.00% | -54.55% |
| Total Other Current Liabilities | 237.50% | 700.00% | -98.41% | 1,160.00% | -54.55% |
| Total Current Liabilities | -44.23% | 26.20% | 0.93% | 61.20% | 8.85% |
|
|
|||||
| Total Current Liabilities | -44.23% | 26.20% | 0.93% | 61.20% | 8.85% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -44.23% | 26.20% | 0.93% | 61.20% | 8.85% |
|
|
|||||
| Common Stock & APIC | 0.37% | 0.43% | 0.35% | 0.33% | 0.34% |
| Retained Earnings | -2.84% | -3.99% | -3.31% | -6.15% | -5.80% |
| Treasury Stock & Other | 2.56% | 53.95% | -37.19% | -47.39% | -47.85% |
| Total Common Equity | -6.60% | -8.38% | -6.35% | -10.79% | -8.72% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -6.60% | -8.38% | -6.35% | -10.79% | -8.72% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -6.60% | -8.38% | -6.35% | -10.79% | -8.72% |
|
|
|||||